awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50262252-1E0FD967-7E3F-489A-BF51-A4CC7210FE02
Q50262252-1E0FD967-7E3F-489A-BF51-A4CC7210FE02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50262252-1E0FD967-7E3F-489A-BF51-A4CC7210FE02
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients.
P2860
Q50262252-1E0FD967-7E3F-489A-BF51-A4CC7210FE02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50262252-1E0FD967-7E3F-489A-BF51-A4CC7210FE02
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e848520b66cbf7dd9e5d491019c8060eabed6ddb
P2860
12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens.